返回 Agenda
Session 6, Track 3: How to Make the Most of an Evolving Tech Landscape Crowded with Competing Solutions: Survival of the Fittest vs Symbiosis?
Session Chair(s)
Matthias Sijtstra
Senior Consultant
Main5 GmbH & Co. KGaA, Netherlands
This session will describe, differentiate and discuss the distinct approaches life sciences regulatory organizations have taken in acquiring, combining, and eliminating new innovative capabilities to optimize their digitalization journey. This session will include use cases from three different Life Companies of various sizes and illustrate their decision-making processes in evaluating, deploying, and managing digital capabilities. They will share their business needs, technical and process issues, design and decision-making frameworks, results, and key learnings.
Learning Objective : At the conclusion of this session, participants should be able to:- Differentiate and assess strategic approaches for digitalization in life sciences
- Apply decision-making frameworks to tech evaluation
- Address challenges in digital adoption with limited resources
Speaker(s)
Author
Salim Saglam, MBA
Genentech, Inc., United States
Business Transformation Lead, Product Development
Speaker
Jessica Romero
Sarepta Therapeutics, United States
Director, Global Regulatory Operations, Global Regulatory Affairs
Speaker
Jason Moyer, MBA
Gilead, United States
Executive Director Reg Affairs Innovation, Digital & External Partnerships